
Sign up to save your podcasts
Or


The Medmen/Pharmacann acquisition passing DOJ regulatory hurdle is BIG news. Here's why:
- What is the DOJ 2nd Request Process?
- Why this is SO important to US Cannabis stocks?
- Which MSOs will benefit from this announcement?
- What this means going forward for US Weed Stocks?
- Are investors fully appreciating how important this is?
- How is the weed market performing since the August lows?
- Which weed stocks will benefit from this?
- Update on the Origin House trade
By CIN Podcast4.6
6767 ratings
The Medmen/Pharmacann acquisition passing DOJ regulatory hurdle is BIG news. Here's why:
- What is the DOJ 2nd Request Process?
- Why this is SO important to US Cannabis stocks?
- Which MSOs will benefit from this announcement?
- What this means going forward for US Weed Stocks?
- Are investors fully appreciating how important this is?
- How is the weed market performing since the August lows?
- Which weed stocks will benefit from this?
- Update on the Origin House trade

3,394 Listeners

3,073 Listeners

937 Listeners

94 Listeners

195 Listeners

82 Listeners

9,840 Listeners

500 Listeners

248 Listeners

349 Listeners

107 Listeners

8 Listeners

13 Listeners

7 Listeners

149 Listeners